- Home
- CPAC vs FATE Comparison
CPAC vs FATE Comparison
Compare CPAC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- FATE
- Stock Information
- Founded
- CPAC 1949
- FATE 2007
- Country
- CPAC Peru
- FATE United States
- Employees
- CPAC N/A
- FATE N/A
- Industry
- CPAC Building Materials
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPAC Industrials
- FATE Health Care
- Exchange
- CPAC Nasdaq
- FATE Nasdaq
- Market Cap
- CPAC 475.3M
- FATE 406.5M
- IPO Year
- CPAC 2012
- FATE 2013
- Fundamental
- Price
- CPAC $5.71
- FATE $1.27
- Analyst Decision
- CPAC Sell
- FATE Hold
- Analyst Count
- CPAC 1
- FATE 10
- Target Price
- CPAC $6.00
- FATE $6.75
- AVG Volume (30 Days)
- CPAC 8.3K
- FATE 3.2M
- Earning Date
- CPAC 02-12-2025
- FATE 02-24-2025
- Dividend Yield
- CPAC 9.51%
- FATE N/A
- EPS Growth
- CPAC 7.38
- FATE N/A
- EPS
- CPAC 0.12
- FATE N/A
- Revenue
- CPAC $527,798,215.00
- FATE $13,447,000.00
- Revenue This Year
- CPAC N/A
- FATE N/A
- Revenue Next Year
- CPAC N/A
- FATE N/A
- P/E Ratio
- CPAC $9.80
- FATE N/A
- Revenue Growth
- CPAC N/A
- FATE N/A
- 52 Week Low
- CPAC $5.00
- FATE $1.04
- 52 Week High
- CPAC $6.65
- FATE $8.83
- Technical
- Relative Strength Index (RSI)
- CPAC 52.63
- FATE 31.94
- Support Level
- CPAC $5.37
- FATE $1.22
- Resistance Level
- CPAC $6.20
- FATE $1.36
- Average True Range (ATR)
- CPAC 0.18
- FATE 0.15
- MACD
- CPAC 0.05
- FATE -0.02
- Stochastic Oscillator
- CPAC 51.51
- FATE 24.21
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.